Esophageal Squamous Cell Carcinoma: all 657 studies
Page 7 of 7. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02041819Phase 2
- Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal CarcinomaWithdrawnNCT02034968Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStatus unknownNCT02025036Phase 3
- Proton Beam Therapy to Treat Esophageal CancerTerminatedNCT02023541Phase 1
- A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the EsophagusTerminatedNCT02017600Phase 2
- Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell CancerStatus unknownNCT02016287Phase 2
- Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell CancerStatus unknownNCT02016274Phase 2
- Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal CarcinomaWithdrawnNCT02011594Phase 2
- Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.Status unknownNCT01993784Phase 1/2
- Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional ChemotherapyCompletedNCT01973725Phase 2
- ESI With EUS to Differentiate T3 and T4 ESCCStatus unknownNCT01930630Phase 1
- S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical StudyCompletedNCT01854749Phase 2
- Study of S-1 in Combination With Radiotherapy in Esophageal CancerCompletedNCT01831531Phase 2
- Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)CompletedNCT01822613Phase 1
- Oral Rigosertib for Squamous Cell CarcinomaCompletedNCT01807546Phase 2
- BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line ChemotherapyTerminatedNCT01806649Phase 2
- Role of Esophagectomy in Complete Responders to CCRTTerminatedNCT01740375Phase 3
- Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)Active, not recruitingNCT01688908Not applicable
- Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT01688700Phase 2
- Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal CancerCompletedNCT01670409Phase 2
- Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell CancerTerminatedNCT01627379Phase 3
- A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusCompletedNCT01608022Phase 2
- Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal CancerCompletedNCT01605305Phase 2
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
- A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT01591135Phase 3
- Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT01561014Phase 1
- Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal CancerCompletedNCT01551589Not applicable
- Genome-wide Association StudyWithdrawnNCT01498757
- Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea PolyphenolsStatus unknownNCT01496521Phase 3
- Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell CarcinomaCompletedNCT01474642Phase 2
- Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT01472419
- Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2
- Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell CarcinomaStatus unknownNCT01467921Phase 2
- Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After EsophagectomyStatus unknownNCT01402180Phase 2/3
- Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0Status unknownNCT01398449Phase 3
- A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal CancerStatus unknownNCT01391572Phase 2
- Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell CancerCompletedNCT01384708Early Phase 1
- A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsCompletedNCT01351103Phase 1
- Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell CancerStatus unknownNCT01336049Phase 2
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2
- Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.TerminatedNCT01248299Phase 2
- Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After ChemotherapyCompletedNCT01243398Phase 3
- Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT01232374Phase 2
- A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of OesophagusStatus unknownNCT01151839Not applicable
- Improve the Treatment of Thoracic Esophageal CancerCompletedNCT01137123Phase 3
- Irinotecan Combined With Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer : a Single Center Prospective Clinical TrialStatus unknownNCT01051765Phase 2
- A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western KenyaCompletedNCT00901173
- Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT00816634Phase 2
- Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT00766480Not applicable
- Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerCompletedNCT00628368Not applicable
- Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma EsophagusTerminatedNCT00239200Phase 2
- Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNCT00220129Phase 2
- A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell CarcinomaTerminatedNCT00190554Phase 3
- Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
- Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal CancerCompletedNCT00072033Phase 2
- Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00045526Phase 2